• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何在临床实践中利用CAT和mMRC评分评估慢性阻塞性肺疾病患者的症状状态?

How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?

作者信息

Ertan Yazar Esra, Niksarlioglu Elif Yelda, Yigitbas Burcu, Bayraktaroglu Mesut

机构信息

Istanbul Medeniyet University Faculty of Medicine, Department of Chest Diseases, Istanbul, Turkey.

University of Health Sciences Turkey, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Clinic of Chest Diseases, Istanbul, Turkey.

出版信息

Medeni Med J. 2022 Jun 23;37(2):173-179. doi: 10.4274/MMJ.galenos.2022.06787.

DOI:10.4274/MMJ.galenos.2022.06787
PMID:35735170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9234363/
Abstract

OBJECTIVE

In this study, we aimed to investigate the compatibility of modified Medical Research Council (mMRC) and COPD assessment test (CAT) scores of chronic obstructive pulmonary disease (COPD) patients in terms of evaluation of their symptom status.

METHODS

The study was planned as a single-center, cross-sectional study. Statistically four separate receiver operating characteristic (ROC) curves of CAT scoring were generated for mMRC scores of 1 to 4.

RESULTS

Two hundred twenty eight patients with stable COPD, mean age 64.2±8.2 and 88.6% male were included. A strong positive correlation was detected between CAT and mMRC (r=0.60, p<0.001). However, it was observed that 32 patients had mMRC<2 but CAT≥10, while 21 patients had CAT<10 but mMRC≥2. Thus, in 53 patients CAT and mMRC scores were not identical in terms of assessed symptom status. According to the ROC analysis, the mMRC scores of 1 to 4 were most compatible with the CAT scores of 10, 10, 15, and 20, respectively.

CONCLUSIONS

Expanding current data represents that CAT score of 10 could be more compatible with mMRC score of 1. Moreover we think although a high mMRC or CAT score may be sufficient to assign patients to high symptom groups, it is needed to evaluate mMRC and CAT together to assign a patient to a low symptom group. In this way misclassification of the patients with high symptoms due to insufficient symptom evaluation as if they have low symptoms can be prevented.

摘要

目的

在本研究中,我们旨在探讨慢性阻塞性肺疾病(COPD)患者改良医学研究委员会(mMRC)评分与慢性阻塞性肺疾病评估测试(CAT)评分在评估其症状状态方面的兼容性。

方法

本研究设计为单中心横断面研究。针对mMRC评分为1至4的情况,统计生成了四条独立的CAT评分受试者工作特征(ROC)曲线。

结果

纳入了228例稳定期COPD患者,平均年龄64.2±8.2岁,男性占88.6%。检测到CAT与mMRC之间存在强正相关(r=0.60,p<0.001)。然而,观察到32例患者mMRC<2但CAT≥10,而21例患者CAT<10但mMRC≥2。因此,在53例患者中,CAT和mMRC评分在评估的症状状态方面并不一致。根据ROC分析,mMRC评分为1至4分别与CAT评分10、1日、15和20最兼容。

结论

现有数据进一步表明,CAT评分为10可能与mMRC评分为1更兼容。此外,我们认为,虽然高mMRC或CAT评分可能足以将患者归为高症状组,但要将患者归为低症状组则需要同时评估mMRC和CAT。这样可以防止因症状评估不足而将高症状患者误分类为低症状患者的情况发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/92ec508eb07c/medj-37-173-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/2dcbf7799e5f/medj-37-173-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/12a161f8f23b/medj-37-173-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/92ec508eb07c/medj-37-173-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/2dcbf7799e5f/medj-37-173-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/12a161f8f23b/medj-37-173-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/9234363/92ec508eb07c/medj-37-173-g3.jpg

相似文献

1
How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?如何在临床实践中利用CAT和mMRC评分评估慢性阻塞性肺疾病患者的症状状态?
Medeni Med J. 2022 Jun 23;37(2):173-179. doi: 10.4274/MMJ.galenos.2022.06787.
2
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
3
Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.使用 COPD 评估测试 (CAT) 或改良版医学研究理事会呼吸困难评分 (mMRC) 对 COPD 组进行分类的差异:一项横断面分析。
BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.
4
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.COPD 评估测试(CAT)与改良版医学研究理事会呼吸困难量表(mMRC)在 COPD 患者临床症状、合并症及医疗资源利用评估方面的比较。
J Formos Med Assoc. 2019 Jan;118(1 Pt 3):429-435. doi: 10.1016/j.jfma.2018.06.018. Epub 2018 Aug 25.
5
Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.慢性阻塞性肺疾病患者临床慢性阻塞性肺疾病问卷的决定因素:一项横断面观察性研究。
Respiration. 2020;99(7):606-616. doi: 10.1159/000507097. Epub 2020 Jul 13.
6
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.
7
Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.以圣乔治呼吸问卷评分25(及20)为参照,根据慢性阻塞性肺疾病全球倡议(GOLD)标准,研究临床慢性阻塞性肺疾病问卷、慢性阻塞性肺疾病评估测试及改良医学研究委员会量表的敏感性、特异性和曲线下面积。
Int J Chron Obstruct Pulmon Dis. 2016 May 18;11:1045-52. doi: 10.2147/COPD.S99793. eCollection 2016.
8
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.改良医学研究委员会呼吸困难量表、慢性阻塞性肺疾病评估测试及临床慢性阻塞性肺疾病问卷在慢性阻塞性肺疾病新全球倡议分期及死亡率中对症状评估的差异效应
Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.
9
Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.慢性阻塞性肺疾病(COPD)患者中与改良医学研究委员会分级相对应的COPD评估测试分数。
Korean J Intern Med. 2015 Sep;30(5):629-37. doi: 10.3904/kjim.2015.30.5.629. Epub 2015 Aug 27.
10
Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study.呼吸症状(COPD 评估测试和改良的医学研究委员会呼吸困难评分)和 GOLD-ABCD COPD 分类:LASSYC 研究。
J Bras Pneumol. 2021 Nov 12;47(5):e20210156. doi: 10.36416/1806-3756/e20210156. eCollection 2021.

引用本文的文献

1
Roles of C-reactive protein and its composite index in predicting acute exacerbation of bronchiectasis.C反应蛋白及其综合指数在预测支气管扩张急性加重中的作用。
Eur J Med Res. 2025 Aug 25;30(1):797. doi: 10.1186/s40001-025-03090-5.
2
Correlation of Parathyroid Hormone Values With Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者甲状旁腺激素值与肺功能参数的相关性
Cureus. 2024 Jul 8;16(7):e64053. doi: 10.7759/cureus.64053. eCollection 2024 Jul.
3
Effect of different doses of Budesonide combined with Tiotropium bromide inhalation on elderly patients with chronic obstructive pulmonary disease.

本文引用的文献

1
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
2
Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study.早期慢性阻塞性肺疾病患者停用噻托溴铵:一项前瞻性观察队列研究。
ERJ Open Res. 2019 Feb 18;5(1). doi: 10.1183/23120541.00175-2018. eCollection 2019 Feb.
3
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
不同剂量布地奈德联合噻托溴铵吸入对老年慢性阻塞性肺疾病患者的影响
Pak J Med Sci. 2024 Aug;40(7):1338-1344. doi: 10.12669/pjms.40.7.9209.
4
Correlation between body composition and disease severity in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者身体成分与疾病严重程度的相关性
Front Med (Lausanne). 2024 Mar 14;11:1304384. doi: 10.3389/fmed.2024.1304384. eCollection 2024.
5
Association Between Sarcopenia and Chronic Renal Failure (Overt and Concealed) in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Cross-Sectional Study.慢性阻塞性肺疾病(COPD)患者中肌肉减少症与慢性肾衰竭(显性和隐性)之间的关联:一项横断面研究
Cureus. 2023 Oct 11;15(10):e46870. doi: 10.7759/cureus.46870. eCollection 2023 Oct.
6
The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.慢性阻塞性肺疾病在实际临床实践中健康状况、呼吸道症状和呼吸困难的概念独立性
Diagnostics (Basel). 2023 Jul 27;13(15):2492. doi: 10.3390/diagnostics13152492.
7
Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study.在一般人群中,气流受限、呼吸困难以及两者的发展:长滨研究。
Sci Rep. 2022 Nov 21;12(1):20060. doi: 10.1038/s41598-022-24657-w.
噻托溴铵治疗早期慢性阻塞性肺疾病。
N Engl J Med. 2017 Sep 7;377(10):923-935. doi: 10.1056/NEJMoa1700228.
4
The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.《2014年更新的全球慢性阻塞性肺疾病倡议(GOLD)策略:不同情景比较》
Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):212-220. doi: 10.15326/jcopdf.1.2.2014.0135.
5
Understanding the impact of symptoms on the burden of COPD.了解症状对慢性阻塞性肺疾病负担的影响。
Respir Res. 2017 Apr 21;18(1):67. doi: 10.1186/s12931-017-0548-3.
6
Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.比较 CAT 与 mMRC 对 COPD 患者特征的影响:一项回顾性、横断面研究。
NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.
7
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
8
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病(COPD)全球倡议(GOLD)分期系统应用于美国基层医疗队列,并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
9
Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand.在新西兰450例初级保健慢性阻塞性肺疾病(COPD)患者中,使用慢性阻塞性肺疾病评估测试(CAT)和改良英国医学研究委员会(mMRC)呼吸困难量表进行慢性阻塞性肺疾病全球倡议(GOLD)分级时,一致性较差。
NPJ Prim Care Respir Med. 2014 Jul 24;24:14025. doi: 10.1038/npjpcrm.2014.25.
10
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.COPDGene 研究中的 GOLD 2011 疾病严重程度分类:一项前瞻性队列研究。
Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3.